Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05591131 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetic Testing in African Americans

Study acronym: GTM-I
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 30 to confirmed 21
    • Site details revised
    v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Nov 2023 to Nov 2027
    • Start date changed from estimate of Nov 2022 to Apr 20, 2023
    • Site details revised
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Study Identification, Study Status, Study Descriptionv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot/feasibility study to conduct genetic testing using tumor/blood samples of African American and Caucasian patients with ovarian and endometrial cancer following surgery at AU Health Medical Center. The aim of the pilot/feasibility study is to sequence a panel of cancer genes on paired tumor/blood (germline) samples of patients with ovarian and endometrial tumors at a two-week time point following surgery at AU Medical Center. While paired testing of tumor and blood (germline) provides direct clinical value to patients, investigators propose to study whether investigators can define and overcome such minority barriers among the Georgia Cancer Center (GCC)/AU Health Medical Center (AUMC) patient population.
Trial Details
NCT Number NCT05591131
Lead Sponsor Augusta University
Conditions
(from sponsor)		 Ovarian Cancer, Endometrial Cancer, Peritoneal Cancer
Related terms Endometrial Neoplasms, Ovarian Neoplasms
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov